We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-6.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$10.4B
AUM Growth
-$1.52B
Cap. Flow
-$723M
Cap. Flow %
-6.93%
Top 10 Hldgs %
32.83%
Holding
1,239
New
73
Increased
466
Reduced
278
Closed
97

Sector Composition

Rank Sector Weight
1 Real Estate 74.77%
2 Technology 3.37%
3 Industrials 3.06%
4 Financials 2.76%
5 Healthcare 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNS
1176
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-56
Closed -$2K
BLCM
1177
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-18
Closed -$1K
JNCE
1178
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-178
Closed -$1K
NH
1179
DELISTED
NantHealth, Inc
NH
-40
Closed -$1K
ZVO
1180
DELISTED
Zovio Inc. Common Stock
ZVO
-6,500
Closed -$66K
TWTR
1181
PUT
DELISTED
Twitter, Inc.
TWTR
-500
Closed -$35K
CTXS
1182
PUT
DELISTED
Citrix Systems Inc
CTXS
-1,192
Closed -$9K
ENDP
1183
DELISTED
Endo International plc
ENDP
-1,234
Closed -$21K
CALA
1184
DELISTED
Calithera Biosciences, Inc
CALA
-10
Closed -$1K
INFO
1185
DELISTED
IHS Markit Ltd. Common Shares
INFO
-164,053
Closed -$8.85M
TLGT
1186
DELISTED
Teligent, Inc
TLGT
-30
Closed -$1K
SBBP
1187
DELISTED
Strongbridge Biopharma plc.
SBBP
-220
Closed -$1K
NEOS
1188
DELISTED
Neos Therapeutics, Inc
NEOS
-160
Closed -$1K
NBRV
1189
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-1
Closed -$1K
DLPH
1190
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
-104,224
Closed -$3.27M
TTPH
1191
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
-14
Closed -$1K
FOMX
1192
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
-207
Closed -$1K
SNNA
1193
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
-113
Closed -$2K
AABA
1194
DELISTED
Altaba Inc
AABA
-63,550
Closed -$4.33M
AABA
1195
PUT
DELISTED
Altaba Inc
AABA
-9,857
Closed -$3.78M
HZNP
1196
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-906
Closed -$18K
AKAO
1197
DELISTED
Achaogen Inc
AKAO
-234
Closed -$1K
USG
1198
DELISTED
Usg
USG
-21,500
Closed -$931K
SGYP
1199
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
-1,363
Closed -$2K
FBR
1200
DELISTED
Fibria Celulose Sa
FBR
-35,900
Closed -$665K

Similar funds

Daiwa Securities Group's Q4 2018 Portfolio in Review

As of Q4 2018, Daiwa Securities Group held 1,239 positions worth $10.4B, down 13% from $11.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $723M in Q4 2018, closing 97 positions and reducing 278 holdings. Its most notable exit was Steris, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 75% of assets, up from 72% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in SITE Centers worth $138M.

  • Daiwa Securities Group's largest Q4 2018 buy was SITE Centers: 16,021,815 shares worth $138M.
  • Daiwa Securities Group added most to American Tower in Q4 2018, an estimated $128M increase.
  • Daiwa Securities Group's biggest Q4 2018 reduction was Crown Castle, cutting an estimated $211M.
  • Daiwa Securities Group fully exited Steris in Q4 2018, selling an estimated $11.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $10.4B portfolio in Q4 2018.
  • Daiwa Securities Group opened 73 new positions and closed 97 in Q4 2018.
  • Daiwa Securities Group's portfolio value fell 13% quarter-over-quarter to $10.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2018, filed 5 Feb 2019.